Navigating 14 Analyst Ratings For Zimmer Biomet Holdings
Portfolio Pulse from Benzinga Insights
Analysts have recently shared mixed ratings on Zimmer Biomet Holdings (NYSE:ZBH), with a notable decrease in the average 12-month price target by 7.29%. The company's financial metrics show strong net margins but challenges in ROE and ROA compared to industry averages.
September 05, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Zimmer Biomet Holdings has received mixed analyst ratings, with a decrease in the average 12-month price target by 7.29%. The company shows strong net margins but faces challenges in ROE and ROA compared to industry averages.
The decrease in the average price target by 7.29% indicates a negative shift in analyst sentiment, which could lead to a short-term decline in stock price. Despite strong net margins, the challenges in ROE and ROA compared to industry averages may also contribute to a bearish outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100